Joshua Gardner

6PUBLICATIONS
16CO-AUTHORS
Molecular medicineMedical infection agents (incl. prions)Predictive and prognostic markersGene and molecular therapyCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 21, 2025
TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity.

Lele Sun, Pengcheng Huai, Zhenzhen Wang

|May 27, 2025
Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS.

Joshua Gardner, Silvia Martinez-Rivera, James Line

|Jun 05, 2024
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.

Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh

|Jan 04, 2024
Glycolysis: An early marker for vancomycin-specific T-cell activation.

Joshua Gardner, Sean Hammond, Rebecca Jensen

|Mar 07, 2023
Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.

Mubarak Almutairi, Adam Lister, Qing Zhao

|Feb 02, 2022
Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01.

Joshua Gardner, Monday Ogese, Catherine J Betts

Pageof 1

Frequent Collaborators

2 joint publications

Xiaoli Meng

1 joint publications

Adam Lister

1 joint publications

James Line

1 joint publications

Kareena Adair